Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation.

Patel N, Veve M, Kwon S, McNutt LA, Fish D, Miller CD.

HIV Med. 2013 Sep;14(8):463-71. doi: 10.1111/hiv.12031. Epub 2013 Mar 18.

2.

Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?

Mayet S, Gossop M, Lintzeris N, Markides V, Strang J.

Drug Alcohol Rev. 2011 Jul;30(4):388-96. doi: 10.1111/j.1465-3362.2010.00237.x. Epub 2010 Sep 6.

PMID:
21355918
3.

Long QTc and torsades de pointes in human immunodeficiency virus disease.

Kocheril AG, Bokhari SA, Batsford WP, Sinusas AJ.

Pacing Clin Electrophysiol. 1997 Nov;20(11):2810-6.

PMID:
9392812
4.

Prevalence and determinants of QT interval prolongation in medical inpatients.

Pasquier M, Pantet O, Hugli O, Pruvot E, Buclin T, Waeber G, Aujesky D.

Intern Med J. 2012 Aug;42(8):933-40. doi: 10.1111/j.1445-5994.2011.02447.x.

PMID:
21299787
5.

Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients.

Tisdale JE, Jaynes HA, Kingery JR, Overholser BR, Mourad NA, Trujillo TN, Kovacs RJ.

Circ Cardiovasc Qual Outcomes. 2014 May;7(3):381-90. doi: 10.1161/CIRCOUTCOMES.113.000651. Epub 2014 May 6. Erratum in: Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):981.

6.

Protease inhibitor-associated QT interval prolongation.

Hunt K, Hughes CA, Hills-Nieminen C.

Ann Pharmacother. 2011 Dec;45(12):1544-50. doi: 10.1345/aph.1Q422. Epub 2011 Nov 29. Review.

PMID:
22128044
7.

Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy.

Vallecillo G, Mojal S, Roquer A, Martinez D, Rossi P, Fonseca F, Muga R, Torrens M.

Clin Infect Dis. 2013 Oct;57(8):1189-94. doi: 10.1093/cid/cit467. Epub 2013 Jul 29.

PMID:
23899678
8.

Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study.

van der Sijs H, Kowlesar R, Klootwijk AP, Nelwan SP, Vulto AG, van Gelder T.

Br J Clin Pharmacol. 2009 Mar;67(3):347-54. doi: 10.1111/j.1365-2125.2008.03357.x. Epub 2008 Dec 10.

9.

Assessment of drug-induced torsade de pointes risk for hospitalized high-risk patients receiving QT-prolonging agents.

Jardin CG, Putney D, Michaud S.

Ann Pharmacother. 2014 Feb;48(2):196-202. doi: 10.1177/1060028013512614. Epub 2013 Dec 3.

PMID:
24301687
10.

Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients.

Nordin C, Kohli A, Beca S, Zaharia V, Grant T, Leider J, Marantz P.

J Electrocardiol. 2006 Apr;39(2):199-205. Epub 2005 Nov 28.

PMID:
16580420
11.

A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.

Greco KE, Tune LE, Brown FW, Van Horn WA.

J Clin Psychiatry. 2005 Jul;66(7):928-9.

PMID:
16013910
12.

Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey.

Benoit SR, Mendelsohn AB, Nourjah P, Staffa JA, Graham DJ.

Eur J Cardiovasc Prev Rehabil. 2005 Aug;12(4):363-8.

PMID:
16079644
13.
14.

Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.

Zeuli JD, Wilson JW, Estes LL.

Antimicrob Agents Chemother. 2013 Mar;57(3):1121-7. doi: 10.1128/AAC.00958-12. Epub 2012 Dec 10.

15.

Outcomes of screening Parkinson's patients for QTc prolongation.

Cunnington AL, Hood K, White L.

Parkinsonism Relat Disord. 2013 Nov;19(11):1000-3. doi: 10.1016/j.parkreldis.2013.07.001. Epub 2013 Jul 17. Review.

PMID:
23871463
16.

QTc prolongation, torsades de pointes, and psychotropic medications.

Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC.

Psychosomatics. 2013 Jan-Feb;54(1):1-13. doi: 10.1016/j.psym.2012.11.001. Review.

PMID:
23295003
17.
18.

Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.

Othong R, Devlin JJ, Kazzi ZN.

Clin Toxicol (Phila). 2015 May;53(4):204-9. doi: 10.3109/15563650.2015.1013547. Epub 2015 Feb 23.

PMID:
25706450
19.

The prevalence and factors associated with QTc prolongation among emergency department patients.

Seftchick MW, Adler PH, Hsieh M, Wolfson AB, Chan ST, Webster BW, Frattaroli GD.

Ann Emerg Med. 2009 Dec;54(6):763-8. doi: 10.1016/j.annemergmed.2009.03.021. Epub 2009 May 6.

PMID:
19419793
20.

Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis.

Pappachan JM, Sebastian J, Bino BC, Jayaprakash K, Vijayakumar K, Sujathan P, Adinegara LA.

Postgrad Med J. 2008 Apr;84(990):205-10. doi: 10.1136/pgmj.2007.064048.

PMID:
18424578

Supplemental Content

Support Center